Free Trial

Generali Asset Management SPA SGR Purchases 7,193 Shares of HCA Healthcare, Inc. $HCA

HCA Healthcare logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Generali Asset Management SPA SGR increased its HCA stake by 63.8%, purchasing 7,193 shares to hold 18,462 shares valued at about $8.62 million at the end of the quarter.
  • Insiders have been net sellers: two senior VPs sold 4,000 and 8,020 shares on Feb. 11 (roughly $2.02M and $4.13M), insiders sold 13,714 shares (~$7.05M) over the last three months and now own 1.50% of the company.
  • Analyst sentiment remains mildly positive — the consensus is a "Moderate Buy" with an average target of $517.82 despite several firms trimming targets; HCA trades around $429 and has FY2026 guidance of 29.10–31.50 EPS.
  • MarketBeat previews the top five stocks to own by June 1st.

Generali Asset Management SPA SGR raised its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 63.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,462 shares of the company's stock after purchasing an additional 7,193 shares during the quarter. Generali Asset Management SPA SGR's holdings in HCA Healthcare were worth $8,619,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of HCA. Brighton Jones LLC acquired a new position in HCA Healthcare during the 4th quarter valued at approximately $1,021,000. NewEdge Advisors LLC increased its stake in HCA Healthcare by 11.9% during the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company's stock valued at $1,334,000 after purchasing an additional 409 shares in the last quarter. Sivia Capital Partners LLC boosted its holdings in shares of HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company's stock valued at $241,000 after acquiring an additional 33 shares during the last quarter. Jump Financial LLC purchased a new stake in shares of HCA Healthcare in the 2nd quarter valued at $2,073,000. Finally, Sei Investments Co. boosted its holdings in shares of HCA Healthcare by 56.3% in the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company's stock valued at $52,328,000 after acquiring an additional 49,214 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

Insider Activity

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total value of $2,020,000.00. Following the completion of the sale, the senior vice president directly owned 44,379 shares in the company, valued at $22,411,395. This represents a 8.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Jennifer Berres sold 8,020 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the sale, the senior vice president owned 11,993 shares of the company's stock, valued at $6,171,357.94. This trade represents a 40.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 13,714 shares of company stock worth $7,050,460 over the last three months. Insiders own 1.50% of the company's stock.

Analysts Set New Price Targets

Several research firms have recently commented on HCA. Truist Financial dropped their price objective on shares of HCA Healthcare from $546.00 to $535.00 and set a "buy" rating on the stock in a report on Monday, April 27th. Sanford C. Bernstein dropped their price objective on shares of HCA Healthcare from $541.00 to $503.00 and set a "market perform" rating on the stock in a report on Tuesday, April 28th. TD Cowen dropped their price objective on shares of HCA Healthcare from $561.00 to $500.00 and set a "buy" rating on the stock in a report on Monday, April 27th. Mizuho increased their price target on shares of HCA Healthcare from $540.00 to $585.00 and gave the stock an "outperform" rating in a report on Wednesday, February 25th. Finally, Argus lowered their price target on shares of HCA Healthcare from $560.00 to $500.00 and set a "buy" rating on the stock in a report on Monday. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $517.82.

Check Out Our Latest Research Report on HCA Healthcare

HCA Healthcare Stock Down 0.1%

HCA opened at $429.20 on Friday. The company has a market cap of $95.21 billion, a price-to-earnings ratio of 14.76, a PEG ratio of 1.36 and a beta of 1.18. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52. The firm's fifty day simple moving average is $491.54 and its two-hundred day simple moving average is $486.57.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion for the quarter, compared to analysts' expectations of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business's revenue for the quarter was up 4.3% on a year-over-year basis. During the same period in the previous year, the business earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 30.05 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare's dividend payout ratio is 10.73%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Further Reading

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in HCA Healthcare Right Now?

Before you consider HCA Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.

While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines